Informatics approaches to assessing patient frailty in surgical care

评估外科护理中患者虚弱程度的信息学方法

基本信息

项目摘要

ABSTRACT Surgical complications are common, costly, and deadly. Older patients are at high risk of adverse surgical outcomes, especially when they exhibit frailty. Frailty is a state of decreased physiologic reserve and loss of capacity to adapt to stressors. Over the past decade, while frailty has been increasingly recognized as an important risk factor for poor surgical outcomes, integration of a standardized frailty metric into clinical care has not been achieved. A key barrier is that existing frailty assessments are not standardized, objective, or widely available, limiting their routine application in surgical decision-making. With the long-term goal of improving surgical care for older adults, we will evaluate two “e-frailty” metrics that can be automatically derived from electronic or digital data that are already collected as part of routine clinical care. These e-frailty metrics include, first, granular patient profiles of electronic health record (EHR) data (risk scores based on claims data or on physiologic and laboratory values), and second, muscle loss assessed from pre-surgical computed tomography (CT) scans (low skeletal muscle mass, known as sarcopenia, and fatty infiltration into muscle indicative of reduced physical function, known as myosteatosis). In Aim 1, we will calculate these two e-frailty metrics among a diverse population of over 41,000 abdominal surgical patients; characterize the overlap between patients designated as frail by the two e-frailty metrics; and evaluate their associations with 30-day readmission and other adverse surgical outcomes (30-day and 1-year mortality, complications, non-home discharge, and length of stay >7 days). In Aim 2, we will compare the performance of e-frailty metrics for predicting 30-day readmission and other adverse surgical outcomes to that of standard risk stratification tools (acute and chronic illness severity metrics) already embedded in EHRs today using cross-validation and an independent validation dataset of over 14,000 more recent abdominal surgeries. In Aim 3, we will examine whether e-frailty metrics modify the benefits that patients derive from achieving postoperative targets -including early and sustained mobilization- in one of the largest Enhanced Recovery After Surgery (ERAS) programs in the nation. We will examine e-frailty metrics as salient indicators of biologic age for predicting morbidity and mortality. In sum, e-frailty metrics show great promise for identifying high-risk patients in the surgical domain, but they need to be integrated within clinical workflows to be scalable and sustainable. This proposal will compute standardized e-frailty metrics automatically derived from EHR data and provide new information regarding the potential value of these e-frailty metrics for improving surgical care for older adults. This study will also lay the groundwork for future prospective interventions integrating e-frailty metrics into clinical care to improve risk stratification and counseling of patients considering surgery and enhance perioperative care for frail surgical patients.
抽象的 手术并发症是常见,昂贵且致命的。老年患者患不良手术的高风险 结果,尤其是当他们暴露脆弱时。脆弱是生理储备和损失的状态 适应压力源的能力。在过去的十年中,虽然脆弱的人越来越被认为是 不良手术结果的重要危险因素,将标准化脆弱指标整合到临床护理中的重要危险因素已有 没有实现。一个关键的障碍是现有的脆弱评估不是标准化,客观或广泛的 可用,限制其在手术决策中的常规应用。具有改进的长期目标 对于老年人的手术护理,我们将评估两个可以自动从 作为常规临床护理的一部分,已经收集的电子或数字数据。这些电子费用指标 首先包括电子健康记录(EHR)数据的颗粒状患者概况(根据索赔数据的风险评分 或关于物理和实验室的值),其次,根据手术前计算的肌肉损失 断层扫描(CT)扫描(骨骼肌质量低,称为肌肉减少症,脂肪浸润到肌肉中 在AIM 1中,我们将计算这两个电子费用 超过41,000名腹部手术患者的潜水员人口的指标;表征重叠 在两个电子费用指标中指定为脆弱的患者之间;并评估他们的关联30天 再入院和其他不良手术结果(30天和1年死亡率,并发症,非家庭 出院和住宿时间> 7天)。在AIM 2中,我们将比较E-Frailty指标的性能 预测标准风险分层工具的30天再入院和其他不良手术结果 (急性和慢性病严重程度指标)今天已经嵌入了EHR中 在AIM 3中,我们将检查 电子费用指标是否会改变患者从实现术后目标中获得的好处 - 包括 早期和持续动员 - 在手术后最大的康复之一(ERA)计划中的动员 国家。我们将研究电子限制指标是预测发病率和的生物年龄的显着指标 死亡。总而言之,电子费用指标在识别手术领域中的高危患者方面表现出巨大的希望, 但是它们需要集成到临床工作流程中,以扩展和可持续。该提议将 计算标准化的电子限制指标自动从EHR数据派生并提供新信息 关于这些电子费用指标在改善老年人手术护理方面的潜在价值。这项研究 还将为将来的前瞻性干预措施奠定基础 改善患者的风险分层和咨询考虑手术并提高周期性护理 脆弱的手术患者。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Quantifying Frailty Requires a Conceptual Model Before a Statistical Model-Reply.
量化衰弱需要在统计模型回复之前建立概念模型。
  • DOI:
    10.1001/jamasurg.2022.3113
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    16.9
  • 作者:
    Le,SidneyT;Liu,VincentX;CespedesFeliciano,ElizabethM
  • 通讯作者:
    CespedesFeliciano,ElizabethM
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Elizabeth Marjorie Cespedes Feliciano其他文献

Elizabeth Marjorie Cespedes Feliciano的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Elizabeth Marjorie Cespedes Feliciano', 18)}}的其他基金

Understanding the role of adiposity and adipokine-related RNA expression in the tumor microenvironment on breast cancer outcomes in a racially and ethnically diverse sample
了解肿瘤微环境中肥胖和脂肪因子相关 RNA 表达对种族和民族多样化样本中乳腺癌结果的作用
  • 批准号:
    10602753
  • 财政年份:
    2022
  • 资助金额:
    $ 58.85万
  • 项目类别:
Body composition and breast cancer survival: immune and metabolic biomarkers in breast tumors
身体成分和乳腺癌生存:乳腺肿瘤中的免疫和代谢生物标志物
  • 批准号:
    10029647
  • 财政年份:
    2020
  • 资助金额:
    $ 58.85万
  • 项目类别:
Body composition and breast cancer survival: immune and metabolic biomarkers in breast tumors
身体成分和乳腺癌生存:乳腺肿瘤中的免疫和代谢生物标志物
  • 批准号:
    10198876
  • 财政年份:
    2020
  • 资助金额:
    $ 58.85万
  • 项目类别:
Informatics approaches to assessing patient frailty in surgical care
评估外科护理中患者虚弱程度的信息学方法
  • 批准号:
    10242206
  • 财政年份:
    2020
  • 资助金额:
    $ 58.85万
  • 项目类别:
D3-creatine dilution to determine skeletal muscle mass in colon cancer patients
D3-肌酸稀释液测定结肠癌患者的骨骼肌质量
  • 批准号:
    10337029
  • 财政年份:
    2020
  • 资助金额:
    $ 58.85万
  • 项目类别:
Informatics approaches to assessing patient frailty in surgical care
评估外科护理中患者虚弱程度的信息学方法
  • 批准号:
    10407652
  • 财政年份:
    2020
  • 资助金额:
    $ 58.85万
  • 项目类别:
Body composition and breast cancer survival: immune and metabolic biomarkers in breast tumors
身体成分和乳腺癌生存:乳腺肿瘤中的免疫和代谢生物标志物
  • 批准号:
    10425385
  • 财政年份:
    2020
  • 资助金额:
    $ 58.85万
  • 项目类别:
D3-creatine dilution to determine skeletal muscle mass in colon cancer patients
D3-肌酸稀释液测定结肠癌患者的骨骼肌质量
  • 批准号:
    10579981
  • 财政年份:
    2020
  • 资助金额:
    $ 58.85万
  • 项目类别:
Body composition and breast cancer survival: immune and metabolic biomarkers in breast tumors - Disparities Supplement
身体成分和乳腺癌生存:乳腺肿瘤中的免疫和代谢生物标志物 - Disparities Supplement
  • 批准号:
    10712034
  • 财政年份:
    2020
  • 资助金额:
    $ 58.85万
  • 项目类别:
Body composition and breast cancer survival: immune and metabolic biomarkers in breast tumors
身体成分和乳腺癌生存:乳腺肿瘤中的免疫和代谢生物标志物
  • 批准号:
    10665682
  • 财政年份:
    2020
  • 资助金额:
    $ 58.85万
  • 项目类别:

相似国自然基金

阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
  • 批准号:
    82302281
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
  • 批准号:
    82300697
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
  • 批准号:
    22304039
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
RNA甲基转移酶NSUN2介导SCD1 mRNA m5C修饰调控急性髓系白血病细胞铁死亡的机制研究
  • 批准号:
    82300173
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于IRF5/MYD88信号通路调控巨噬细胞M1极化探讨针刀刺营治疗急性扁桃体炎的机制研究
  • 批准号:
    82360957
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

A Novel Assay to Improve Translation in Analgesic Drug Development
改善镇痛药物开发转化的新方法
  • 批准号:
    10726834
  • 财政年份:
    2023
  • 资助金额:
    $ 58.85万
  • 项目类别:
Towards Precision Rehabilitation for Ventral Hernia
腹疝的精准康复
  • 批准号:
    10823864
  • 财政年份:
    2023
  • 资助金额:
    $ 58.85万
  • 项目类别:
MECHANISMS OF VISCERAL PAIN DRIVEN BY SMALL INTESTINAL MICROBIOTA
小肠微生物驱动内脏疼痛的机制
  • 批准号:
    10836298
  • 财政年份:
    2023
  • 资助金额:
    $ 58.85万
  • 项目类别:
Development of a Novel Animal Model for Spinal Cord Injury with Sepsis
脓毒症脊髓损伤新型动物模型的开发
  • 批准号:
    10665862
  • 财政年份:
    2023
  • 资助金额:
    $ 58.85万
  • 项目类别:
Integration of non-invasive deep tissue microwave thermometry in the VectRx hyperthermia device in a transgenic liver tumor pig model
在转基因肝肿瘤猪模型中将非侵入性深部组织微波测温技术集成到 VectRx 热疗装置中
  • 批准号:
    10697183
  • 财政年份:
    2023
  • 资助金额:
    $ 58.85万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了